Folinic Acid Market: Introduction
In 1945, folinic acid was firstly made, and later World Health Organization was added folinic acid in the list of essential medicines. Folinic acid is the safest and effective medicines needed in the health system. Folinic acid is an activated form of vitamin B9 and folic acid.
Folinic acid is also known as calcium folinate or leucovorin. Folinic acid is used as a medication to reduce the toxic effects of pyrimethamine and methotrexate. Also, usage of folinic acid as supplements to provide higher levels of glutathione and dopamine in individuals with autism is promoting consumption across the globe.
Moreover, folinic acid is also used in a blend with 5-fluorouracil to treat cancer, folate deficiency, and methanol poisoning. It serves as in the form of pills, injection into veins and muscles. Folic acid, folate, and folinic acid are all forms of water-soluble vitamin B9. In food grains, folate occurs naturally, while folinic acid is synthetically formulated by various process and that is found in medicinal supplements and fortified foods.
Folinic Acid Market: Dynamics
Across the globe, the pharmaceutical and food & beverage industry growth has led to the consumption of folinic acid. Continuous investment in research and development to develop advanced and effective medical solution are contributing to the growth of the pharmaceutical industry, which in turn, expected to drive the global folinic acid market.
An aging population coupled with several diseases such as cancer, and rheumatoid arthritis, among others, are also expected to legs folinic acid consumption around the world. Increasing folinic acid application in cancer treatment via chemotherapy to reduce the effect of chemotherapy and make them efficient cancer treatment process.
Moreover, going up medical technology to develop high-quality folic acid tablets that are used as a necessary add-on during pregnancy has also led the folinic acid market growth. Several benefits associated with folinic acid such as the consumption of folinic acid can be reduced the threat of genetic debilities.
Such aspects are projected to lay a strong platform for the extensive growth of the folinic acid demand during the foreseen trajectory of the market. Moreover, in many developed countries, vitamin B9 powder is mandatory to add in the food grains and pulses, such factor is positively impacting on the folinic acid market growth in the coming years.
However, various stringent regulations and standards for commercial use of folinic acid are anticipated to constraints the demand across the globe in the coming years.
Folinic Acid Market: Regional Outlook
From the geographical view, North America followed by Europe is estimated to account for dominating share in the global folinic acid market. The well-established medical industry and continued dominance in the pharmaceutical capital expenditure are expected to make North America one of the most lucrative in the folinic acid market.
Growing attention of prominent firms in the field of medicine to develop an advanced medical solution and they invest a hefty amount in R&D to provide effective and innovative solutions to the healthcare industry. Moreover, the Asia Pacific is projected to witness prominent growth in the global folinic acid market in the coming years.
Emerging economies such as China and India have led the investment in the pharmaceutical and F&B industry and that factor expected to drive the folinic acid market in the coming years. Moreover, Latin America and the Middle East & Africa are expected to register considerable growth in the global folinic acid market in the coming years.
Growing awareness about health-related issues brings new transformation in the pharmaceutical industry and that factor has led market growth in those regions.
Folinic Acid Market: Market participants
Some of the key market participants identified across the value chain of the Folinic Acid market are:
- BASF SE
- Zydus Pharmaceuticals Ltd.
- Medicamen Biotech Ltd.
- DSM N.V.
- Jiangxi Tianxin Pharmaceutical Co. Ltd.
- Emcure Pharmaceutical Ltd.
- Xinjiang Wujiaqu Xingnong Cycle Chemical Co. Ltd.
- PMC Group Inc.
- Clinigen Group Plc
- Pfizer Inc.
- National Vitamin Inc.
- Nutraceutical Corporation
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.
The report covers exhaustive analysis on
- Folinic Acid Market Segments
- Folinic Acid Market Dynamics
- Folinic Acid Market Size
- Folinic Acid Market Supply/Demand
- Folinic Acid Current Trends/Issues/Challenges
- Folinic Acid Competition & Companies involved
- Folinic Acid Value Chain
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Mexico, Brazil)
- Western Europe (Germany, Italy, France, U.K, Spain)
- Eastern Europe (Poland, Russia)
- Asia Pacific (China, India, ASEAN, Australia & New Zealand)
- Middle East and Africa (GCC Countries, S. Africa, Northern Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various factors on the market segments and geographies.
The global folinic acid market can be segmented on the basis of application, and region.
Basis of Application :
- Food and Beverages
Basis of Form: